{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:29:22Z","timestamp":1764250162707,"version":"3.41.2"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["603016, 278948, 602805"],"award-info":[{"award-number":["603016, 278948, 602805"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["728018"],"award-info":[{"award-number":["728018"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2019.00768","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T04:41:37Z","timestamp":1571978497000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Methylphenidate Dose-Dependently Affects Aggression and Improves Fear Extinction and Anxiety in BALB\/cJ Mice"],"prefix":"10.3389","volume":"10","author":[{"given":"Amanda","family":"Jager","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doranda","family":"Kanters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Femke","family":"Geers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan K.","family":"Buitelaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamas","family":"Kozicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey C.","family":"Glennon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200012000-00007","article-title":"Oppositional defiant and conduct disorder: a review of the past 10 years, part I","volume":"39","author":"Loeber","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200206000-00007","article-title":"Anxiety and depression symptoms and response to methylphenidate in children with attention-deficit hyperactivity disorder and tic disorder","volume":"22","author":"Gadow","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/jsm005","article-title":"Attention-deficit\/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology","volume":"32","author":"Spencer","year":"2007","journal-title":"J Pediatr Psychol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2013.08.024","article-title":"Callous-unemotional traits, proactive aggression, and treatment outcomes of aggressive children with attention-deficit\/hyperactivity disorder","volume":"52","author":"Blader","year":"2013","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1089\/cap.2015.0167","article-title":"Pharmacotherapy of aggression in child and adolescent psychiatric disorders","volume":"26","author":"Gurnani","year":"2016","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/09540260801887819","article-title":"Pharmacological treatment of pathologic aggression in children","volume":"20","author":"Barzman","year":"2008","journal-title":"Int Rev Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1521\/capn.2011.16.6.1","article-title":"Clinical pharmacology of conduct disorder: a critical review","volume":"16","author":"Lettinga","year":"2011","journal-title":"Child Adolesc Psychopharmacol News"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s11126-013-9253-7","article-title":"Pharmacology and pharmacogenetics of pediatric ADHD with associated aggression: a review","volume":"84","author":"Patel","year":"2013","journal-title":"Psychiatr Q"},{"key":"B9","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.neubiorev.2017.01.024","article-title":"The pharmacological treatment of aggression in children and adolescents with conduct disorder. Do callous-unemotional traits modulate the efficacy of medication","volume":"91","author":"Balia","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"key":"B10","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/chi.0b013e318054e724","article-title":"Practice parameter for the assessment and treatment of children and adolescents with attention-deficit\/hyperactivity disorder","volume":"46","author":"Pliszka","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B11","unstructured":"Attention deficit hyperactivity disorder: diagnosis and management2018"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200203000-00004","article-title":"Psychopharmacology and aggression. I: a meta-analysis of stimulant effects on overt\/covert aggression\u2013related behaviors in ADHD","volume":"41","author":"Connor","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B13","first-page":"27","article-title":"Pharmacotherapy of aggression in children and adolescents: efficacy and effect size","volume":"15","author":"Pappadopulos","year":"2006","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1997.01830240023003","article-title":"Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder","volume":"54","author":"Klein","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/14651858.CD009885.pub2","article-title":"Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)","volume":"351","author":"Storeb\u00f8","year":"2015","journal-title":"Cochr Database Syst Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-198911000-00012","article-title":"Effect of anxiety on cognition, behavior, and stimulant response in ADHD","volume":"28","author":"Pliszka","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199507000-00012","article-title":"Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety","volume":"34","author":"Tannock","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2016.05.009","article-title":"A possible effect of methylphenidate on state anxiety: a single dose, placebo controlled, crossover study in a control group","volume":"241","author":"Segev","year":"2016","journal-title":"Psychiatry Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/ped.12847","article-title":"Anxiety reduction on atomoxetine and methylphenidate medication in children with ADHD","volume":"58","author":"Snircova","year":"2016","journal-title":"Pediatr Int"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/science.337493","article-title":"Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behavior","volume":"198","author":"Sprague","year":"1977","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1101\/lm.033613.113","article-title":"Animal model of methylphenidate\u2019s long-term memory-enhancing effects","volume":"21","author":"Carmack","year":"2014","journal-title":"Learn Mem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1542\/peds.112.5.e404","article-title":"A dose-response study of OROS methylphenidate in children with attention-deficit\/hyperactivity disorder","volume":"112","author":"Stein","year":"2003","journal-title":"Pediatrics"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1037\/e338612004-007","article-title":"Attention deficit disorder with and without hyperactivity: clinical response to three dose levels of methylphenidate","volume":"87","author":"Barkley","year":"1991","journal-title":"Pediatrics"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(67)90040-4","article-title":"Pharmacological control of aggressive behavior in mice","volume":"2","author":"Valzelli","year":"1967","journal-title":"Eur J Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF00426957","article-title":"Intruder-evoked aggression in isolated and nonisolated mice: effects of psychomotor stimulants and L-dopa","volume":"57","author":"Miczek","year":"1978","journal-title":"Psychopharmacology (Berl)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2009.03.028","article-title":"Behavioral abnormality and pharmacologic response in social isolation-reared mice","volume":"202","author":"Koike","year":"2009","journal-title":"Behav Brain Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1101\/lm.024752.111","article-title":"Methylphenidate enhances extinction of contextual fear","volume":"19","author":"Abraham","year":"2012","journal-title":"Learn Mem"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2008.07.025","article-title":"Low sociability is associated with reduced size of the corpus callosum in the BALB\/cJ inbred mouse strain","volume":"1230","author":"Fairless","year":"2008","journal-title":"Brain Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s10519-009-9325-5","article-title":"Differences in aggressive behavior and DNA copy number variants between BALB\/cJ and BALB\/cByJ substrains","volume":"40","author":"Velez","year":"2010","journal-title":"Behav Genet"},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2017.12.007","article-title":"Cortical control of aggression: GABA signalling in the anterior cingulate cortex","volume-title":"Eur Neuropsychopharmacol","author":"Jager","year":"2017"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116642541","article-title":"Perseveration by NK1R-\/- (\u2018knockout\u2019) mice is blunted by doses of methylphenidate that affect neither other aspects of their cognitive performance nor the behaviour of wild-type mice in the 5-Choice Continuous Performance Test","volume":"30","author":"Pillidge","year":"2016","journal-title":"J Psychopharmacol (Oxford, England)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2396(20001215)38:4<432::AID-SYN8>3.0.CO;2-Q","article-title":"Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor","volume":"38","author":"Gerasimov","year":"2000","journal-title":"Synapse"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033693","article-title":"Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice","volume":"7","author":"Sadasivan","year":"2012","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/0301-0082(80)90024-6","article-title":"The organization of intraspecific agonistic behaviour in the rat","volume":"15","author":"Koolhaas","year":"1980","journal-title":"Progress in Neurobiology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3791\/4367","article-title":"The resident-intruder paradigm: a standardized test for aggression, violence and social stress","author":"Koolhaas","year":"2013","journal-title":"J Vis Exp"},{"volume-title":"Exploratory data analysis","year":"1977","author":"Tukey","key":"B36"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.141713","article-title":"The effects of methylphenidate on knockin mice with a methylphenidate-resistant dopamine transporter","volume":"327","author":"Tilley","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2013.02.010","article-title":"Assessing anxiety in C57BL\/6J mice: a pharmacological characterization of the zero maze test","volume":"68","author":"Heredia","year":"2013","journal-title":"J Pharmacol Toxicol Methods"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2013.12.005","article-title":"Assessing anxiety in C57BL\/6J mice: a pharmacological characterization of the open-field and light\/dark tests","volume":"69","author":"Heredia","year":"2014","journal-title":"J Pharmacol Toxicol Methods"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1538\/expanim.60.111","article-title":"Strain and sex differences in anxiety-like and social behaviors in C57BL\/6J and BALB\/cJ mice","volume":"60","author":"An","year":"2011","journal-title":"Exp Anim"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1038\/tp.2014.82","article-title":"Methylphenidate and desipramine combined treatment improves PTSD symptomatology in a rat model","volume":"4","author":"Aga-Mizrachi","year":"2014","journal-title":"Transl Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2017.03.027","article-title":"Extinction memory is facilitated by methylphenidate and regulated by dopamine and noradrenaline receptors","volume":"326","author":"Furini","year":"2017","journal-title":"Behav Brain Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/dev.1047","article-title":"Effects of chronic and acute methylphenidate hydrochloride (Ritalin) administration on locomotor activity, ultrasonic vocalizations, and neuromotor development in 3- to 11-day-old CD-1 mouse pups","volume":"39","author":"Penner","year":"2001","journal-title":"Dev Psychobiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1744-9081-2-3","article-title":"Dose-response characteristics of methylphenidate on locomotor behavior and on sensory evoked potentials recorded from the VTA, NAc, and PFC in freely behaving rats","volume":"2","author":"Yang","year":"2006","journal-title":"Behav Brain Funct"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199307000-00022","article-title":"Fenfluramine and methylphenidate in children with mental retardation and ADHD: clinical and side effects","volume":"32","author":"Aman","year":"1993","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.v02n0502","article-title":"Methylphenidate abuse and psychiatric side effects","volume":"2","author":"Morton","year":"2000","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1097\/00008480-200204000-00013","article-title":"Abuse and toxicity of methylphenidate","volume":"14","author":"Klein-Schwartz","year":"2002","journal-title":"Curr Opin Pediatr"},{"key":"B48","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2018.06.001","article-title":"Intoxicated aggression: Do alcohol and stimulants cause dose-related aggression? A review","volume-title":"Eur Neuropsychopharmacol","author":"Kuypers","year":"2018"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S114185","article-title":"Changes in behavior as side effects in methylphenidate treatment: review of the literature","volume":"12","author":"Konrad-Bindl","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.06.017","article-title":"Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo","volume":"68","author":"Hannestad","year":"2010","journal-title":"Biol Psychiatry"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.04.022","article-title":"Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function","volume":"60","author":"Berridge","year":"2006","journal-title":"Biol Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","first-page":"i6","DOI":"10.1093\/cercor\/bhm033","article-title":"Catecholamine and second messenger influences on prefrontal cortical networks of \u201crepresentational knowledge\u201d: a rational bridge between genetics and the symptoms of mental illness","volume":"17","author":"Arnsten","year":"2007","journal-title":"Cereb Cortex"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s12402-011-0063-1","article-title":"Adjunctive atomoxetine to SSRIs or SNRIs in the treatment of adult ADHD patients with comorbid partially responsive generalized anxiety (GA): an open-label study","volume":"3","author":"Gabriel","year":"2011","journal-title":"Attention Deficit Hyperactivity Disord"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2009.07.008","article-title":"Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit\/hyperactivity disorder and comorbid oppositional defiant disorder: a placebo-controlled Italian study","volume":"19","author":"Dell\u2019Agnello","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2013.0029","article-title":"Combination use of atomoxetine hydrochloride and olanzapine in the treatment of attention-deficit\/hyperactivity disorder with comorbid disruptive behavior disorder in children and adolescents 10-18 years of age","volume":"23","author":"Holzer","year":"2013","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1177\/2045125316647686","article-title":"Efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in patients with common comorbidities in children, adolescents and adults: a review","volume":"6","author":"Hutchison","year":"2016","journal-title":"Ther Adv Psychopharmacol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jpsychires.2018.03.009","article-title":"Response inhibition and emotional cognition improved by atomoxetine in children and adolescents with ADHD: the ACTION randomized controlled trial","volume":"102","author":"Griffiths","year":"2018","journal-title":"J Psychiatr Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1990.tb04599.x","article-title":"Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals","volume":"55","author":"Carboni","year":"1990","journal-title":"J Neurochem"},{"key":"B59","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","article-title":"Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit\/hyperactivity disorder","volume":"27","author":"Bymaster","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2010.06.015","article-title":"Methylphenidate and atomoxetine enhance prefrontal function through \u03b12-adrenergic and dopamine D1 receptors","volume":"49","author":"Gamo","year":"2010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2012.11.005","article-title":"Psychostimulants and motivated behavior: arousal and cognition","volume":"37","author":"Berridge","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"B62","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2210-6-6","article-title":"Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs","volume":"6","author":"Han","year":"2006","journal-title":"BMC Pharmacol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2015.0075","article-title":"Meta-analysis: reduced risk of anxiety with psychostimulant treatment in children with attention-deficit\/hyperactivity disorder","volume":"25","author":"Coughlin","year":"2015","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.17-21-08528.1997","article-title":"Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance","volume":"17","author":"Zahrt","year":"1997","journal-title":"J Neurosci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-03-01208.2000","article-title":"Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex","volume":"20","author":"Granon","year":"2000","journal-title":"J Neurosci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2005.11.055","article-title":"A functional magnetic resonance imaging study of the effects of pergolide, a dopamine receptor agonist, on component processes of working memory","volume":"139","author":"Gibbs","year":"2006","journal-title":"Neuroscience"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00768\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T04:41:41Z","timestamp":1571978501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00768\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":66,"alternative-id":["10.3389\/fpsyt.2019.00768"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2019.00768","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2019,10,25]]},"article-number":"768"}}